Literature DB >> 17931161

Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.

Terry D Connell1.   

Abstract

The heat-labile enterotoxins expressed by Vibrio cholerae (cholera toxin) and Escherichia coli (LT-I, LT-IIa and LT-IIb) are potent systemic and mucosal adjuvants. Coadministration of the enterotoxins with a foreign antigen produces an augmented immune response to that antigen. Although each enterotoxin has potent adjuvant properties, the means by which the enterotoxins induce various immune responses are distinctive for each adjuvant. Various mutants have been engineered to dissect the functions of the enterotoxins required for their adjuvanticity. The capacity to strongly bind to one or more specific ganglioside receptors appears to drive the distinctive immunomodulatory properties associated with each enterotoxin. Mutant enterotoxins with ablated or altered ganglioside-binding affinities have been employed to investigate the role of gangliosides in enterotoxin-dependent immunomodulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931161      PMCID: PMC2849181          DOI: 10.1586/14760584.6.5.821

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  137 in total

1.  Induction of cytotoxic T lymphocyte responses by cholera toxin-treated bone marrow-derived dendritic cells.

Authors:  Myoung Ho Jang; Mi Na Kweon; Takachika Hiroi; Masafumi Yamamoto; Ichiro Takahashi; Hiroshi Kiyono
Journal:  Vaccine       Date:  2003-04-02       Impact factor: 3.641

2.  In vivo adjuvant-induced mobilization and maturation of gut dendritic cells after oral administration of cholera toxin.

Authors:  Fabienne Anjuère; Carmelo Luci; Michael Lebens; Déborah Rousseau; Catherine Hervouet; Geneviève Milon; Jan Holmgren; Carlos Ardavin; Cecil Czerkinsky
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

3.  Splenic marginal zone dendritic cells mediate the cholera toxin adjuvant effect: dependence on the ADP-ribosyltransferase activity of the holotoxin.

Authors:  Dubravka Grdic; Lena Ekman; Karin Schön; Kristina Lindgren; Johan Mattsson; Karl-Eric Magnusson; Paola Ricciardi-Castagnoli; Nils Lycke
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

4.  Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

Authors:  N Lycke; J Holmgren
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

5.  Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB.

Authors:  S Tamura; H Funato; T Nagamine; C Aizawa; T Kurata
Journal:  Vaccine       Date:  1989-12       Impact factor: 3.641

6.  Micellar properties of glycosphingolipids in aqueous media.

Authors:  B Ulrich-Bott; H Wiegandt
Journal:  J Lipid Res       Date:  1984-11       Impact factor: 5.922

7.  Association of the GPI-anchored leucocyte surface glycoproteins with ganglioside GM3.

Authors:  B Kniep; T Cinek; P Angelisová; V Horejsí
Journal:  Biochem Biophys Res Commun       Date:  1994-09-15       Impact factor: 3.575

8.  MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants.

Authors:  C P Simmons; P Mastroeni; R Fowler; M Ghaem-maghami; N Lycke; M Pizza; R Rappuoli; G Dougan
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

9.  The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.

Authors:  E J Park; J H Chang; J S Kim; J S Yum; S I Chung
Journal:  Exp Mol Med       Date:  2000-06-30       Impact factor: 8.718

10.  The Type II heat-labile enterotoxins LT-IIa and LT-IIb and their respective B pentamers differentially induce and regulate cytokine production in human monocytic cells.

Authors:  George Hajishengallis; Hesham Nawar; Richard I Tapping; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

View more
  44 in total

1.  Increased immunogenicity to LipL32 of Leptospira interrogans when expressed as a fusion protein with the cholera toxin B subunit.

Authors:  Alejandra Habarta; Patricia A E Abreu; Noelia Olivera; Pricila Hauk; Maia T Cédola; María F Ferrer; Paulo L Ho; Ricardo M Gomez
Journal:  Curr Microbiol       Date:  2010-08-19       Impact factor: 2.188

2.  Expression and Regulation of Cholecystokinin Receptor in the Chicken's Immune Organs and Cells.

Authors:  Seham El-Kassas; Solomon Odemuyiwa; George Hajishengallis; Terry D Connell; Toufic O Nashar
Journal:  J Clin Cell Immunol       Date:  2016-11-25

3.  Transcutaneous immunization with cross-reacting material CRM(197) of diphtheria toxin boosts functional antibody levels in mice primed parenterally with adsorbed diphtheria toxoid vaccine.

Authors:  Paul Stickings; Marisa Peyre; Laura Coombes; Sylviane Muller; Rino Rappuoli; Giuseppe Del Giudice; Charalambos D Partidos; Dorothea Sesardic
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

Review 4.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

Review 5.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

Review 6.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

7.  Partial synthesis of ganglioside and lysoganglioside lipoforms as internal standards for MS quantification.

Authors:  Martin Gantner; Günter Schwarzmann; Konrad Sandhoff; Thomas Kolter
Journal:  J Lipid Res       Date:  2014-10-22       Impact factor: 5.922

Review 8.  Heat-labile enterotoxins as adjuvants or anti-inflammatory agents.

Authors:  Shuang Liang; George Hajishengallis
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

9.  Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometry.

Authors:  Weiwei Zhao; Hans Minderman; Michael W Russell
Journal:  Clin Vaccine Immunol       Date:  2013-11-06

Review 10.  Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration.

Authors:  Ronald L Schnaar; Rita Gerardy-Schahn; Herbert Hildebrandt
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.